TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22476985

Group type: EXPERIMENTAL
Intervention: Patient activation intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 100
Study: 19127485

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 0
Study: 17403281

Group type: EXPERIMENTAL
Intervention: Extended pancreaticoduodenectomy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard pancreaticoduodenectomy
Number of subjects: 11
Study: 15064100

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 281

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 281
Study: 11777965

Group type: EXPERIMENTAL
Intervention: CD40L + IL-1beta
Number of subjects: 0

Group type: COMPARATOR
Intervention: CD40L
Number of subjects: 0
Study: 10353375

Group type: COMPARATOR
Intervention: Healthy adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Schizophrenic adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Schizophrenic adults (left visual field)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Schizophrenic adults (right visual field)
Number of subjects: 0
Study: 1907566

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (100-200 mg daily)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 6136346

Group type: EXPERIMENTAL
Intervention: Purified allergen preparation from Timothy pollen (Timothy N)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Crude extract from Timothy pollen (Timothy O)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Four-grass pollen mixture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not hyposensitized)
Number of subjects: 60
Study: 31973759

Group type: EXPERIMENTAL
Intervention: Motivational interviewing-based patient empowerment program (PEP), 4 sessions over 1 month
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Motivational interviewing-based patient empowerment program (PEP)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Traditional lecture-style health education on DM (Control)
Number of subjects: 225
Study: 30765503

Group type: EXPERIMENTAL
Intervention: Electronic Asthma Management System (eAMS)
Number of subjects: 3497
Study: 27807040

Group type: EXPERIMENTAL
Intervention: Combined intervention of albendazole (single dose), zinc (14 days), and daily multiple micronutrient powder for 24 weeks
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo group (no interventions)
Number of subjects: 254
Study: 26272782

Group type: EXPERIMENTAL
Intervention: EMPOWER intervention (experimental group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy Lifestyles (active control intervention)
Number of subjects: 0
Study: 24952392

Group type: EXPERIMENTAL
Intervention: Bioactive stents
Number of subjects: 501

Group type: COMPARATOR
Intervention: Drug-eluting stents
Number of subjects: 501
Study: 22928615

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) applied on the right side of jaws (GaAlAs LLLT, 670 nm, 5 mW, 14 min/day for five consecutive days)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (periodontitis only)
Number of subjects: 300
Study: 21181567

Group type: EXPERIMENTAL
Intervention: Functional multidisciplinary rehabilitation
Number of subjects: 109

Group type: COMPARATOR
Intervention: Outpatient physiotherapy
Number of subjects: 109
Study: 18179322

Group type: EXPERIMENTAL
Intervention: Needs-based model of reconciliation
Number of subjects: 0
Study: 16162784

Group type: EXPERIMENTAL
Intervention: 4 mL of 4% lidocaine (160 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: 4 mL of saline solution as placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined sedation with 5 mg of IV hydrocodone and midazolam
Number of subjects: 150
Study: 14550328

Group type: EXPERIMENTAL
Intervention: Intervention group (home-based early intervention with weekly visits for 6 months and biweekly visits from 6 to 18 months)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Both groups (parenting stress and child abuse potential)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Children's development (mental, motor, and language)
Number of subjects: 161
Study: 10382078

Group type: EXPERIMENTAL
Intervention: Triphasic norgestimate/35 micrograms ethinyl estradiol (NGM/EE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monophasic norethindrone acetate/20 micrograms ethinyl estradiol (NETA/EE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both OC
Number of subjects: 0
Study: 9378845

Group type: EXPERIMENTAL
Intervention: Nicotine patch (day 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine patch followed by nicotine gum (day 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine patch followed by nicotine gum and cigarette smoking (day 4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicoderm during exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Habitrol during exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both Nicoderm and Habitrol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Habitrol
Number of subjects: 0
Study: 8200309

Group type: EXPERIMENTAL
Intervention: QT dispersion (QTd) in patients with ventricular fibrillation
Number of subjects: 62

Group type: COMPARATOR
Intervention: QT dispersion (QTd) in patients without ventricular fibrillation
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: JT dispersion (JTd) in patients with ventricular fibrillation
Number of subjects: 62

Group type: COMPARATOR
Intervention: JT dispersion (JTd) in patients without ventricular fibrillation
Number of subjects: 62
Study: 3946752

Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Cefoperazone
Number of subjects: 147

Group type: COMPARATOR
Intervention: Combination therapy (clindamycin and gentamicin)
Number of subjects: 147
Study: 30165984

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (100 μg)
Number of subjects: 16485

Group type: EXPERIMENTAL
Intervention: Vilanterol (25 μg)
Number of subjects: 16485

Group type: EXPERIMENTAL
Intervention: Combination of fluticasone furoate and vilanterol
Number of subjects: 16485

Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 16485

Group type: EXPERIMENTAL
Intervention: Highest quintile of cardiac troponin (≥7.7 ng/l)
Number of subjects: 16485

Group type: EXPERIMENTAL
Intervention: Exacerbations
Number of subjects: 16485
Study: 28033633

Group type: EXPERIMENTAL
Intervention: SMAS lifting with predominantly oblique-vertical vectors
Number of subjects: 107

Group type: COMPARATOR
Intervention: SMAS lifting with predominantly oblique-horizontal vectors
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Sutures placed in specific areas for platysmal plication
Number of subjects: 107

Group type: COMPARATOR
Intervention: Randomly placed sutures for platysmal plication
Number of subjects: 107
Study: 25277740

Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Head-up tilt (HUT) in CFS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Head-up tilt (HUT) in control subjects
Number of subjects: 26
Study: 23194213

Group type: EXPERIMENTAL
Intervention: 15-hour day shifts
Number of subjects: 12
Study: 20620737

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg load, then 90 mg twice daily; n=57)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Clopidogrel (600 mg load, then 75 mg daily; n=54)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo (n=12)
Number of subjects: 123
Study: 19166421

Group type: EXPERIMENTAL
Intervention: Metronidazole-containing therapy (lansoprazole 15 mg once-daily, amoxicillin 500 mg twice-daily, metronidazole 250 mg twice-daily)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Clarithromycin-containing therapy (lansoprazole 15 mg once-daily, amoxicillin 500 mg twice-daily, clarithromycin 250 mg once-daily)
Number of subjects: 238
Study: 16041208

Group type: EXPERIMENTAL
Intervention: Laparoscopic choledochotomy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Postoperative ERCP
Number of subjects: 86
Study: 11833038

Group type: EXPERIMENTAL
Intervention: Transdermal 50 microg/d estradiol for 12 weeks (estrogen replacement therapy [ERT])
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Transdermal 50 microg/d estradiol for 12 weeks (ERT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 10028105

Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Famciclovir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiviral therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Episodic or suppressive treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type-specific serological tests for HSV antibodies
Number of subjects: 0
Study: 7720153

Group type: EXPERIMENTAL
Intervention: Clonidine (5 micrograms.kg‐1 po)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 80
Study: 1672878

Group type: EXPERIMENTAL
Intervention: Levocabastine (0.5 mg/ml), nasal spray, twice in each nostril, four times a day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Levocabastine (0.5 mg/ml)
Number of subjects: 100
Study: 6754384

Group type: EXPERIMENTAL
Intervention: Betamethasone 9 mg (Celeston Chronodose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30412233

Group type: EXPERIMENTAL
Intervention: Community of Voices choir intervention
Number of subjects: 390

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention for 6 months)
Number of subjects: 390
Study: 30732169

Group type: EXPERIMENTAL
Intervention: Avaxim
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Epaxal
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Havrix
Number of subjects: 108
Study: 28922068

Group type: EXPERIMENTAL
Intervention: Flaxseed lignan-enriched complex (600 mg SDG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26478977

Group type: EXPERIMENTAL
Intervention: Osteopenia group (n = 13)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups at baseline and 4 months after surgery
Number of subjects: 24
Study: 23340005

Group type: EXPERIMENTAL
Intervention: Low-dose itraconazole (200 mg/day)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: High-dose itraconazole (600 mg/day)
Number of subjects: 46
Study: 21332024

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Candesartan
Number of subjects: 22
Study: 19809292

Group type: EXPERIMENTAL
Intervention: Recruitment maneuver + PEEP
Number of subjects: 30

Group type: COMPARATOR
Intervention: PEEP alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Recruitment maneuver + zero end-expiratory pressure
Number of subjects: 30

Group type: COMPARATOR
Intervention: General anesthesia (induction)
Number of subjects: 30
Study: 17348989

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg/day for 12 months
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 34
Study: 15096079

Group type: EXPERIMENTAL
Intervention: Oral treatment with 2 mg of risperidone plus 2 mg of lorazepam
Number of subjects: 162

Group type: COMPARATOR
Intervention: Intramuscular treatment with 5 mg of haloperidol plus 2 mg of lorazepam
Number of subjects: 162
Study: 11803349

Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 44
Study: 9835726

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Spinal/Epidural techniques
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Combined Anesthesia (GA + S/Ep.)
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Intramuscular route for postoperative analgesia (POA)
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Nonsteroidal antiinflammatory drugs (NSAIDs)
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Epidural Analgesia (EA)
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Local anesthetics-opioids association (LA + Op) for epidural analgesia
Number of subjects: 2435
Study: 8182811

Group type: EXPERIMENTAL
Intervention: Intensive surveillance (n = 655) including physician visits, bone scan, liver echography, chest roentgenography, and laboratory tests at predefined intervals
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Control regimen (n = 665) with physician visits and only clinically indicated tests
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Both groups received a yearly mammogram
Number of subjects: 1320
Study: 2924690

Group type: EXPERIMENTAL
Intervention: Diuretic combination (hydrochlorothiazide + triamterene)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Digitalis glycoside
Number of subjects: 16
Study: 29630702

Group type: EXPERIMENTAL
Intervention: Varenicline, 1 mg twice daily
Number of subjects: 8058

Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride, 150 mg twice daily
Number of subjects: 8058

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy, 21‐mg/d patch with tapering
Number of subjects: 8058

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8058
Study: 27655905

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy (6 courses of modified infusional fluorouracil and folinic acid with oxaliplatin before and after surgery)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Postoperative chemotherapy (modified infusional fluorouracil and folinic acid with oxaliplatin; 12 cycles)
Number of subjects: 330
Study: 25901451

Group type: EXPERIMENTAL
Intervention: XR-NTX
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 22043026

Group type: EXPERIMENTAL
Intervention: Number Sense Instruction (NSI)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 101
Study: 20643454

Group type: EXPERIMENTAL
Intervention: Biofeedback-pelvic floor muscle training once a week for 3 months and home exercises
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (no biofeedback training)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Biofeedback-pelvic floor muscle training
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups (treatment and control)
Number of subjects: 73
Study: 18486739

Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Maintenance ustekinumab
Number of subjects: 766

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 766
Study: 16905398

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy with family unit including the patient
Number of subjects: 87

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy with a group of relatives
Number of subjects: 87
Study: 12840177

Group type: EXPERIMENTAL
Intervention: Encapsulated mixed extract (Juice Plus)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 32
Study: 10788287

Group type: EXPERIMENTAL
Intervention: Social support intervention administered by nurse and peer advisors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 8706290

Group type: EXPERIMENTAL
Intervention: 3% saline infusion followed by oral water load (10 ml/kg over 3 minutes)
Number of subjects: 38
Study: 1829098

Group type: EXPERIMENTAL
Intervention: Steroid suppressive agents (aminoglutethimide, ketoconazole, metyrapone) for 2 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Not applicable (discontinuation of other psychotropic drugs)
Number of subjects: 10
Study: 7020903

Group type: EXPERIMENTAL
Intervention: Combination therapy with melphalan, 5-fluorouracil, and methotrexate
Number of subjects: 240

Group type: COMPARATOR
Intervention: Sequential therapy with melphalan followed by 5-fluorouracil and then methotrexate
Number of subjects: 240
Study: 31134632

Group type: EXPERIMENTAL
Intervention: Pegbelfermin (daily and weekly administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29166972

Group type: EXPERIMENTAL
Intervention: Neonatal vitamin A supplementation (any dose)
Number of subjects: 247
Study: 25100233

Group type: EXPERIMENTAL
Intervention: Negative mood (anxious, sad)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive mood (amused)
Number of subjects: 0
Study: 23452658

Group type: EXPERIMENTAL
Intervention: Starplasty tracheotomy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Traditional tracheotomy (Control Group 1)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Traditional tracheotomy (Control Group 2)
Number of subjects: 65
Study: 22303701

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC) administered orally before noise exposure
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo administered orally before noise exposure
Number of subjects: 363
Study: 19640356

Group type: EXPERIMENTAL
Intervention: Desoxypeganine 50 mg (b.i.d. for 3 days)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Desoxypeganine 100 mg (b.i.d. for 3 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 17676355

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (pre-treatment results)
Number of subjects: 20
Study: 15626322

Group type: EXPERIMENTAL
Intervention: Emotional reasoning
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Parent-based reasoning
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: High levels of anxiety and depression
Number of subjects: 508
Study: 11344201

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (200 mg/week, im)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (3 times/week)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No training
Number of subjects: 54

Group type: COMPARATOR
Intervention: Men with AIDS wasting
Number of subjects: 54

Group type: COMPARATOR
Intervention: Controls (35 age-matched healthy non-HIV-infected subjects)
Number of subjects: 54
Study: 9671187

Group type: EXPERIMENTAL
Intervention: Surgical drain
Number of subjects: 202

Group type: COMPARATOR
Intervention: No drain
Number of subjects: 202
Study: 8013019

Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine echocardiography (5-10 mcg/kg/min over 5 min)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High-dose dobutamine echocardiography (20-40 mcg/kg/min over 3 min)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Dipyridamole echocardiography (0.56 mg/kg over 4 min + 0.28 mg/kg over 2 min)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Dobutamine echocardiography
Number of subjects: 47

Group type: COMPARATOR
Intervention: Dipyridamole echocardiography
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Late spontaneous functional recovery
Number of subjects: 47
Study: 2583149

Group type: EXPERIMENTAL
Intervention: 5 mg of caffeine per kg of body-weight in 200 ml of orange juice (CA)
Number of subjects: 5

Group type: COMPARATOR
Intervention: 200 ml of orange juice (C)
Number of subjects: 5
Study: 133601

Group type: EXPERIMENTAL
Intervention: High initial dosage of 2,500 mg aurothioglucose in 21 weeks, followed by maintenance dosage
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Low dosage of 1,000 mg gold in 21 weeks, followed by maintenance dosage
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo injections after high dosage
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo injections after low dosage
Number of subjects: 196
Study: 29065052

Group type: EXPERIMENTAL
Intervention: Caffeine (80 mg) and Taurine (1 g)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (maltodextrin ∼1 g)
Number of subjects: 11
Study: 31634648

Group type: EXPERIMENTAL
Intervention: ED (75 mg/m2 of epirubicin and 75 mg/m2 of docetaxel)
Number of subjects: 3010

Group type: COMPARATOR
Intervention: FEC (500 mg/m2 of fluorouracil, 100 mg/m2 of epirubicin and 500 mg/m2 of cyclophosphamide)
Number of subjects: 3010

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 3010
Study: 28573704

Group type: EXPERIMENTAL
Intervention: Video-based skills training intervention
Number of subjects: 285

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 285
Study: 25813214

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 2250

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 2250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2250
Study: 23722666

Group type: EXPERIMENTAL
Intervention: Remote monitoring
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard arm (conventional method of in-person evaluations)
Number of subjects: 200
Study: 21742425

Group type: EXPERIMENTAL
Intervention: Higher financial autonomy
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Higher participation in decision-making
Number of subjects: 600
Study: 19343970

Group type: EXPERIMENTAL
Intervention: Levodopa/carbidopa (0.50 mg + 1.25 mg per kg body weight three times daily after meals)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Levodopa/carbidopa
Number of subjects: 30
Study: 17329508

Group type: EXPERIMENTAL
Intervention: 1 mg of micronized 17beta‐estradiol (n=96)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo (n=122)
Number of subjects: 218
Study: 15450833

Group type: EXPERIMENTAL
Intervention: Rofecoxib (50 mg preoperatively)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 11504983

Group type: EXPERIMENTAL
Intervention: Discontinuation of PCP prophylaxis
Number of subjects: 273
Study: 9682809

Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 8288661

Group type: EXPERIMENTAL
Intervention: Active ultrasound device
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo control device
Number of subjects: 67